Elevated plasma interleukin-35 levels predict poor prognosis in patients with non-small cell lung cancer

Non–Small Cell Lung Cancer, Version 2.2013

(2017) David S. Ettinger et al.   Journal of the National Comprehensive Cancer Network

IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases

(2014) Ping Shen et al.   NATURE

Circulating IL-35 in pancreatic ductal adenocarcinoma patients

(2013) Peng Jin et al.   HUMAN IMMUNOLOGY

Tumor-Derived IL-35 Promotes Tumor Growth by Enhancing Myeloid Cell Accumulation and Angiogenesis

(2013) Z. Wang et al.   JOURNAL OF IMMUNOLOGY

IL-35 over-expression increases apoptosis sensitivity and suppresses cell growth in human cancer cells

(2012) Jun Long et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

SnapShot: Non-Small Cell Lung Cancer

(2012) Rebecca S. Heist et al.   CANCER CELL

Aberrant expression of Treg-associated cytokine IL-35 along with IL-10 and TGF-β in acute myeloid leukemia

(2012) HAO WU et al.   Oncology Letters

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Identification of Epstein-Barr Virus-Induced Gene 3 as a Novel Serum and Tissue Biomarker and a Therapeutic Target for Lung Cancer

(2011) R. Nishino et al.   CLINICAL CANCER RESEARCH

IL-35 Stimulation of CD39+ Regulatory T Cells Confers Protection against Collagen II-Induced Arthritis via the Production of IL-10

(2010) I. Kochetkova et al.   JOURNAL OF IMMUNOLOGY

IL-35-mediated induction of a potent regulatory T cell population

(2010) Lauren W Collison et al.   NATURE IMMUNOLOGY

Genome-wide analysis displays marked induction of EBI3/IL-27B in IL-18-activated AML-derived KG1 cells: Critical role of two κB binding sites in the human EBI3 promotor

(2008) Marco A. Poleganov et al.   MOLECULAR IMMUNOLOGY